SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.53-2.8%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LarryS who wrote (14052)7/11/2000 9:17:37 AM
From: Bluegreen  Read Replies (1) of 17367
 
Larry what about these questions??? What are the chances of Lilly buying Xoma???? I don't believe they filed that patent just for fun like Cacaito would have you to believe. The patent was VERY SPECIFIC right down to the in depth TREATMENT PROTOCOL!!!!!!! Any idiot knows that courts don't uphold overly broad patents. The more specific the patent the better. In my opinion I think Baxter and Xoma will have to respond BIGTIME to the patent by LILLY. Lilly has their view of the future and by their patent filing BPI is part of their view of the future. WHY ARE THESE COMPANIES SO INTERESTED IN BPI????????? WHY??????? LILLY PICKED BPI TO USE IN COMBO WITH PROTEIN C................ONCE AGAIN WHY??????
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext